Standard Life Private Equity (SLPE) has announced results for the year ended 30 September 2020. Over the period the trust produced an NAV total return of 11.7%. This compares to a return of -16.6% from the All-Share Index. The total shareholder return was -4.6%. [Here is the killer stat:] The company has delivered returns in excess of the wider market in all years since inception.
Quarterly dividends of 3.3p totalled 13.2p for the year, 3.1% up on the previous year.
In response to the pandemic, the board and manager adopted a deliberately cautious approach. Over the company’s financial year, SLPE made commitments totalling £140.0m (2019: £188.0m) into six new primary investments, two secondary investments and two co-investments. Outstanding commitments at the year end amounted to £471.4m (2019: £450.3m). The trust has an untapped £200m multi-credit facility that matures in December 2024 plus, at the end of September, cash and cash equivalents of £33.1m, not including a further £15.3m of deferred consideration from investments sold in 2019, which was received after the year end.
SLPE received £140.7m of distributions in the year (2019: £107.4m), realising 3.5 times cost on average for investments sold from its core portfolio. The biggest contributor to realised gains was 3i Eurofund V, as a result of the realisation of its underlying company Action. Excluding 3i Eurofund V, the realised return was 2.3 times (2019: 2.2 times cost).
The company retained some exposure to Action – the largest new investment was a £22.6m co-investment / re-investment into that company. Other notable new investments in the year included:
Visma (Hg Saturn 2 / co-investment) – a European provider of mission-critical software to SMEs;
ERT (Nordic Capital IX) – an international provider of data collection solutions for use in clinical drug development;
All4labels (Triton V) – a European manufacturer of labels for the consumer industry;
Recordati (CVC VII) – an international specialty pharmaceutical group;
Froneri (PAI SPs) – an international ice cream manufacturer; and
Litera (HgCapital 8) – a global provider of software to the legal and life sciences industries.
Source: QuotedData
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.